Found 1 results
Filters: Author is J. Sánchez-Corona  [Clear All Filters]
A. E. Bencomo-Álvarez, Limones-Perches, I., Suarez-Rincon, A. E., Ramírez-Jirano, L. J., Borrayo-Carbajal, E., Sánchez-Corona, J., and Montoya-Fuentes, H., Human papillomavirus viral load in cervical intraepithelial neoplasia as a prognostic factor in a Mexican population, vol. 11, pp. 4720-4727, 2012.
Andersson S, Safari H, Mints M, Lewensohn-Fuchs I, et al. (2005). Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br. J. Cancer 92: 2195-2200. PMid:15942630 PMCid:2361820   Boulet GA, Benoy IH, Depuydt CE, Horvath CA, et al. (2009). Human papillomavirus 16 load and E2/E6 ratio in HPV16- positive women: biomarkers for cervical intraepithelial neoplasia ≥2 in a liquid-based cytology setting? Cancer Epidemiol. Biomarkers Prev. 18: 2992-2999. PMid:19861526   Briolat J, Dalstein V, Saunier M, Joseph K, et al. (2007). HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int. J. Cancer 121: 2198-2204. PMid:17657742   Cain JM and Howett MK (2000). Preventing cervical cancer. Science 288: 1753-1755. PMid:10877694   Castle PE, Schiffman M and Wheeler CM (2004). Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer. Am. J. Obstet. Gynecol. 191: 1590-1597. PMid:15547529   Castle PE, Schiffman M, Scott DR, Sherman ME, et al. (2005). Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiol. Biomarkers Prev. 14: 1311-1314. PMid:15894692   Castle PE, Solomon D, Wheeler CM, Gravitt PE, et al. (2008). Human papillomavirus genotype specificity of hybrid capture 2. J. Clin. Microbiol. 46: 2595-2604. PMid:18579716 PMCid:2519476   Clavel C, Masure M, Bory JP, Putaud I, et al. (2001). Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br. J. Cancer 84: 1616-1623. PMid:11401314 PMCid:2363679   Einstein MH (2008). Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines. Cancer Immunol. Immunother. 57: 443-451. PMid:18157723   Fiander AN, Hart KW, Hibbitts SJ, Rieck GC, et al. (2007). Variation in human papillomavirus type-16 viral load within different histological grades of cervical neoplasia. J. Med. Virol. 79: 1366-1369. PMid:17607770   Grce M, Matovina M, Milutin-Gasperov N and Sabol I (2010). Advances in cervical cancer control and future perspectives. Coll. Antropol. 34: 731-736. PMid:20698164   Hesselink AT, Berkhof J, Heideman DA, Bulkmans NW, et al. (2009). High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer. Int. J. Cancer 124: 381-386. PMid:19003961   Ho GY, Burk RD, Klein S, Kadish AS, et al. (1995). Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. 87: 1365-1371. PMid:7658497   Javier RT and Butel JS (2008). The history of tumor virology. Cancer Res. 68: 7693-7706. PMid:18829521 PMCid:3501656   Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, et al. (2000). Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2189-2193.   Lillo FB and Uberti-Foppa C (2006). Human papillomavirus viral load: a possible marker for cervical disease in HIV-infected women. J. Antimicrob. Chemother. 57: 810-814. PMid:16556637   Lorincz AT, Castle PE, Sherman ME, Scott DR, et al. (2002). Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360: 228-229.   McMurray HR, Nguyen D, Westbrook TF and McAnce DJ (2001). Biology of human papillomaviruses. Int. J. Exp. Pathol. 82: 15-33. PMid:11422538 PMCid:2517699   Mendizabal-Ruiz AP, Morales JA, Ramirez-Jirano LJ, Padilla-Rosas M, et al. (2009). Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res. Treat. 114: 189-194. PMid:18373273   Moberg M, Gustavsson I, Wilander E and Gyllensten U (2005). High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br. J. Cancer 92: 891-894. PMid:15756259 PMCid:2361906   Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, et al. (1999). Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354: 20-25.   Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, et al. (2001). Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 358: 1782-1783.   Remmink AJ, Walboomers JM, Helmerhorst TJ, Voorhorst FJ, et al. (1995). The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int. J. Cancer 61: 306-311. PMid:7729939   Sargent A, Bailey A, Turner A, Almonte M, et al. (2010). Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial. J. Clin. Microbiol. 48: 554-558. PMid:20007387 PMCid:2815647   Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, et al. (2003). Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int. J. Cancer 103: 519-524. PMid:12478669   Seaman WT, Andrews E, Couch M, Kojic EM, et al. (2010). Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR. Virol. J. 7: 194. PMid:20723234 PMCid:2933591   Sun CA, Lai HC, Chang CC, Neih S, et al. (2001). The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol. Oncol. 83: 95-99. PMid:11585419   Sun CA, Liu JF, Wu DM, Nieh S, et al. (2002). Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int. J. Gynaecol. Obstet. 76: 41-47.   Wensveen CW, Kagie MJ, Nagelkerke NJ, Veldhuizen RW, et al. (2005). Can viral load, semi-quantitatively evaluated, of human papillomavirus predict cytological or histological outcome in women with atypical squamous or glandular cells of undetermined significance cytology? Eur. J. Gynaecol. Oncol. 26: 393-397. PMid:16122186   Winer RL, Lee SK, Hughes JP, Adam DE, et al. (2003). Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am. J. Epidemiol. 157: 218-226. PMid:12543621   Xi LF, Kiviat NB, Galloway DA, Zhou XH, et al. (2008). Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3. J. Infect. Dis. 198: 324-331. PMid:18627250 PMCid:2784608   Xu Y, Dotto J, Hui Y, Lawton K, et al. (2009). High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger. Int. J. Clin. Exp. Pathol. 2: 169-175. PMid:19079652 PMCid:2583634   Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, et al. (2000). Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2194-2198.   Zielinski GD, Snijders PJ, Rozendaal L, Voorhorst FJ, et al. (2001). HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br. J. Cancer 85: 398-404. PMid:11487272 PMCid:2364067